Clinical Trials Browser

Phase 1 × Biliary Tract Neoplasms × tocilizumab × Clear all

NCT04338685 2024-12-09

A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases

Phase 1 Completed

55 enrolled 30 charts

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular